Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Dec;26(6):781–786. doi: 10.1111/j.1365-2125.1988.tb05319.x

Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.

J G Kelly 1, G D Doyle 1, M Carmody 1, D R Glover 1, W D Cooper 1
PMCID: PMC1386595  PMID: 2853960

Abstract

1. Lisinopril and enalapril were administered as 2.5 mg single doses and as eight single daily 2.5 mg doses to separate groups of six patients with chronic renal failure. Patients were receiving regular haemodialysis. 2. In the absence of haemodialysis, the decline in plasma concentrations of lisinopril and enalaprilat was extremely slow and plasma concentrations were generally high. 3. Haemodialysis had large effects on plasma concentrations of lisinopril and enalaprilat. A 4 h period reduced plasma concentrations of both drugs by around one-half and often by significantly more than this. Even 1 or 2 h of haemodialysis had significant effects. 4. Haemodialysis plasma clearance was similar for both drugs with mean values of the order of 40 ml min-1. Clearance did not markedly differ when measured after 1, 2 or 4 h of haemodialysis or after single or multiple doses of lisinopril or enalapril. 5. The design of dosage regimens of both lisinopril and enalapril for patients with severe renal impairment or chronic renal failure should take into consideration the use and effects of haemodialysis.

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kelly J. G., Doyle G., Donohue J., Laher M., Vandenburg M. J., Currie W. J., Cooper W. D. Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol. 1986 Jan;21(1):63–69. doi: 10.1111/j.1365-2125.1986.tb02823.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Lowenthal D. T., Irvin J. D., Merrill D., Saris S., Ulm E., Goldstein S., Hichens M., Klein L., Till A., Harris K. The effect of renal function on enalapril kinetics. Clin Pharmacol Ther. 1985 Dec;38(6):661–666. doi: 10.1038/clpt.1985.242. [DOI] [PubMed] [Google Scholar]
  3. Sennesael J., Verbeelen D. Intra-individual comparison of captopril and enalapril in patients undergoing regular haemodialysis. Eur J Clin Pharmacol. 1986;30(3):257–262. doi: 10.1007/BF00541524. [DOI] [PubMed] [Google Scholar]
  4. Ulm E. H., Hichens M., Gomez H. J., Till A. E., Hand E., Vassil T. C., Biollaz J., Brunner H. R., Schelling J. L. Enalapril maleate and a lysine analogue (MK-521): disposition in man. Br J Clin Pharmacol. 1982 Sep;14(3):357–362. doi: 10.1111/j.1365-2125.1982.tb01991.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. van Schaik B. A., Geyskes G. G., Boer P. Lisinopril in hypertensive patients with and without renal failure. Eur J Clin Pharmacol. 1987;32(1):11–16. doi: 10.1007/BF00609951. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES